These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30879125)

  • 1. Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.
    Lu VM; Welby JP; Mahajan A; Laack NN; Daniels DJ
    Childs Nerv Syst; 2019 May; 35(5):739-746. PubMed ID: 30879125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
    Mankuzhy NP; Tringale KR; Dunkel IJ; Farouk Sait S; Souweidane MM; Khakoo Y; Karajannis MA; Wolden S
    Pediatr Blood Cancer; 2024 May; 71(5):e30929. PubMed ID: 38430472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
    Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
    Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
    Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
    J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reirradiation for diffuse intrinsic pontine glioma: prognostic radiomic factors at progression.
    Wawrzuta D; Chojnacka M; Drogosiewicz M; Pędziwiatr K; Dembowska-Bagińska B
    Strahlenther Onkol; 2024 Sep; 200(9):797-804. PubMed ID: 38748214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.
    Amsbaugh MJ; Mahajan A; Thall PF; McAleer MF; Paulino AC; Grosshans D; Khatua S; Ketonen L; Fontanilla H; McGovern SL
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):144-148. PubMed ID: 30610915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma.
    Hayashi A; Ito E; Omura M; Aida N; Tanaka M; Tanaka Y; Sato H; Miyagawa N; Yokosuka T; Iwasaki F; Hamanoue S; Goto H
    Pediatr Int; 2020 Jan; 62(1):47-51. PubMed ID: 31785177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.
    Shi S; Lu S; Jing X; Liao J; Li Q
    World Neurosurg; 2021 Apr; 148():e565-e571. PubMed ID: 33476781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
    Zamora PL; Miller SR; Kovoor JJ
    Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
    Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
    J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.
    Lassaletta A; Strother D; Laperriere N; Hukin J; Vanan MI; Goddard K; Lafay-Cousin L; Johnston DL; Zelcer S; Zapotocky M; Rajagopal R; Ramaswamy V; Hawkins C; Tabori U; Huang A; Bartels U; Bouffet E
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26988. PubMed ID: 29369515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric diffuse intrinsic pontine glioma: where do we stand?
    Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
    Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.
    Krishnatry R; Manjali JJ; Chinnaswamy G; Chatterjee A; Goda JS; Janu A; Sahu A; Jalali R; Gupta T
    Jpn J Clin Oncol; 2021 Apr; 51(5):762-768. PubMed ID: 33521824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
    Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
    Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma.
    Tinkle CL; Simone B; Chiang J; Li X; Campbell K; Han Y; Li Y; Hover LD; Molitoris JK; Becksfort J; Lucas JT; Patay Z; Baker SJ; Broniscer A; Merchant TE
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):838-847. PubMed ID: 31785339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.
    Rechberger JS; Lu VM; Zhang L; Power EA; Daniels DJ
    Childs Nerv Syst; 2020 Jan; 36(1):39-46. PubMed ID: 31489454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: A systematic review and meta-analysis.
    Park J; Yea JW; Park JW
    Medicine (Baltimore); 2020 Oct; 99(42):e22721. PubMed ID: 33080729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
    El-Khouly FE; Veldhuijzen van Zanten SEM; Santa-Maria Lopez V; Hendrikse NH; Kaspers GJL; Loizos G; Sumerauer D; Nysom K; Pruunsild K; Pentikainen V; Thorarinsdottir HK; Rutkauskiene G; Calvagna V; Drogosiewicz M; Dragomir M; Deak L; Kitanovski L; von Bueren AO; Kebudi R; Slavc I; Jacobs S; Jadrijevic-Cvrlje F; Entz-Werle N; Grill J; Kattamis A; Hauser P; Pears J; Biassoni V; Massimino M; Lopez Aguilar E; Torsvik IK; Joao Gil-da-Costa M; Kumirova E; Cruz-Martinez O; Holm S; Bailey S; Hayden T; Thomale UW; Janssens GOR; Kramm CM; van Vuurden DG
    J Neurooncol; 2019 Oct; 145(1):177-184. PubMed ID: 31522324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
    Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
    Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.